Education
About Us
Working with TipRanks
Follow Us
XP (XP)
NASDAQ:XP
XP Analyst Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
XP Stock 12 Month Forecast
Average Price Target
$23.50
▲(32.32% Upside)
| Highest Price Target$26.00 | Average Price Target$23.50 | Lowest Price Target$22.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
$22
Hold
23.87%
Upside
Reiterated
12/12/25
XP's Strategic Initiatives and Market Conditions Lead to Neutral Rating Amid Limited Earnings GrowthWe met with Thiago Maffra (CEO) to discuss company strategy and key themes for ’26. Mr. Maffra highlighted 3 focus areas: i) company efforts to standardize services provided by IFAs, ii) expanding premium services to lower-tier customers and iii) developing alternative distribution channels. We maintain our earnings estimates relatively unchanged, which reflect limited revenue yield improvement and higher investments in the B2C channel, constraining earnings growth to 8% in ’26.
Morgan Stanley
$26
Buy
46.40%
Upside
Reiterated
11/17/25
Optimistic Outlook for XP: Strong Q3 Performance and Positive Market Indicators Support Buy RatingWe think these will come as a positive surprise to market participants, particularly on the back of recent management commentary on challenging inflow dynamics and softness in capital markets (here). Meanwhile, AUC and COGS were roughly in line with consensus. On the negative side, retail revenue, take rate, and operating expenses fell short of expectations. During the conference call, management reiterated its retail net inflow guidance (~R$20 bn per quarter) and that it can still achieve the low-end of its 2026 targets. All told, we expect XP shares to perform well tomorrow. Reiterate Overweight on XP.
UBS
$24→$23
Buy
29.50%
Upside
Reiterated
10/16/25
Citi
$22→$23
Buy
29.50%
Upside
Assigned
09/24/25
XP Inc: Buy Rating Affirmed Amid Attractive Valuation and Future Interest Rate BenefitsWe rate XP as Buy. Despite the postponement of market activity resumption, we remain constructive on XP’s ability to grow. Also, XP is trading at a valuation discount, and we expect a strong payout for 2025E and 2026E.
Itau Unibanco
$21
Hold
18.24%
Upside
Downgraded
06/22/25
Goldman Sachs
$23
Buy
29.50%
Upside
Upgraded
06/04/25
Banco Santander
$22
Buy
23.87%
Upside
Upgraded
05/28/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
$22
Hold
23.87%
Upside
Reiterated
12/12/25
XP's Strategic Initiatives and Market Conditions Lead to Neutral Rating Amid Limited Earnings GrowthWe met with Thiago Maffra (CEO) to discuss company strategy and key themes for ’26. Mr. Maffra highlighted 3 focus areas: i) company efforts to standardize services provided by IFAs, ii) expanding premium services to lower-tier customers and iii) developing alternative distribution channels. We maintain our earnings estimates relatively unchanged, which reflect limited revenue yield improvement and higher investments in the B2C channel, constraining earnings growth to 8% in ’26.
Morgan Stanley
$26
Buy
46.40%
Upside
Reiterated
11/17/25
Optimistic Outlook for XP: Strong Q3 Performance and Positive Market Indicators Support Buy RatingWe think these will come as a positive surprise to market participants, particularly on the back of recent management commentary on challenging inflow dynamics and softness in capital markets (here). Meanwhile, AUC and COGS were roughly in line with consensus. On the negative side, retail revenue, take rate, and operating expenses fell short of expectations. During the conference call, management reiterated its retail net inflow guidance (~R$20 bn per quarter) and that it can still achieve the low-end of its 2026 targets. All told, we expect XP shares to perform well tomorrow. Reiterate Overweight on XP.
UBS
$24→$23
Buy
29.50%
Upside
Reiterated
10/16/25
Citi
$22→$23
Buy
29.50%
Upside
Assigned
09/24/25
XP Inc: Buy Rating Affirmed Amid Attractive Valuation and Future Interest Rate BenefitsWe rate XP as Buy. Despite the postponement of market activity resumption, we remain constructive on XP’s ability to grow. Also, XP is trading at a valuation discount, and we expect a strong payout for 2025E and 2026E.
Itau Unibanco
$21
Hold
18.24%
Upside
Downgraded
06/22/25
Goldman Sachs
$23
Buy
29.50%
Upside
Upgraded
06/04/25
Banco Santander
$22
Buy
23.87%
Upside
Upgraded
05/28/25
Best Analysts Covering XP
1 Month
xxx
Success Rate
7/11 ratings generated profit
Average Return
+2.88%
upgraded a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 63.64% of your transactions generating a profit, with an average return of +2.88% per trade.
3 Months
xxx
Success Rate
7/10 ratings generated profit
Average Return
+15.22%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 70.00% of your transactions generating a profit, with an average return of +15.22% per trade.
1 Year
Success Rate
7/11 ratings generated profit
Average Return
+20.89%
upgraded a buy rating 6 months ago
Copying Tito Labarta's trades and holding each position for 1 Year would result in 63.64% of your transactions generating a profit, with an average return of +20.89% per trade.
2 Years
xxx
Success Rate
7/11 ratings generated profit
Average Return
+5.95%
upgraded a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 63.64% of your transactions generating a profit, with an average return of +5.95% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
XP Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
0
0
0
0
0
Buy
9
13
11
10
4
Hold
2
4
5
8
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
17
16
18
11
Each month's total comprises the sum of three months' worth of ratings.
XP Financial Forecast
XP Stock Forecast FAQ
What is XP’s average 12-month price target, according to analysts?
Based on analyst ratings, XP’s 12-month average price target is 23.50.
What is XP’s upside potential, based on the analysts’ average price target?
XP has 32.32% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is XP a Buy, Sell or Hold?
XP has a consensus rating of Strong Buy which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
What is XP’s price target?
The average price target for XP is 23.50. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $26.00 ,the lowest forecast is $22.00. The average price target represents 32.32% Increase from the current price of $17.76.
The highest analyst price target is $26.00 ,the lowest forecast is $22.00. The average price target represents 32.32% Increase from the current price of $17.76.
What do analysts say about XP?
XP’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of XP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.